Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million
News provided by
Share this article
GOTHENBURG, Sweden, May 18, 2021 /PRNewswire/
Isofol Medical AB s (publ), (Nasdaq First North Premier Growth Market: ISOFOL), ( Isofol or the Company ) Board of Directors has today, pursuant to the authorization granted by the extraordinary general meeting held on May 14, 2021 ( the EGM ), resolved on an issue of shares of a maximum of 62,524,474 shares with preferential rights for the Company s existing shareholders (the Rights Issue ). The subscription price in the Rights Issue is SEK 6.40 per share. If the Rights Issue is fully subscribed, the Company will receive approximately SEK 400 million before transaction costs related to the Rights Issue. In addition to the Rights Issue, and provided the Rights issue is oversubscribed, the Board of Directors is authorized to carry out a directed share issue with deviation from t
DGAP-Adhoc: Media and Games Invest plc: Evaluation of further debt capital raise to execute on it s M&A pipeline
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.